cidofovir anhydrous has been researched along with Lymphoma, Non-Hodgkin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrei, G; De Clercq, E; Holý, A; Krecmerová, M; Naesens, L; Neyts, J; Snoeck, R; Votruba, I | 1 |
| Barozzi, P; Cavanna, L; Longo, G; Luppi, M; Morselli, M; Potenza, L; Ravazzini, L; Re, A; Riva, G; Roncaglia, R; Rossi, G; Torelli, G; Trovato, R; Vallisa, D | 1 |
| Kulick, KB; Osswald, SS; Sperling, LC; Tomaszewski, MM | 1 |
| Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V | 1 |
4 other study(ies) available for cidofovir anhydrous and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytosine; DNA Replication; DNA Viruses; DNA, Neoplasm; Drug Stability; Female; Herpesvirus 1, Human; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred Strains; Organophosphonates | 2008 |
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cidofovir; Cytosine; Herpesvirus 8, Human; Humans; Injections, Intralesional; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Organophosphonates; Remission Induction; Time Factors | 2005 |
Viral-associated trichodysplasia in a patient with lymphoma: a case report and review.
Topics: Administration, Topical; Aged; Alopecia; Antiviral Agents; Cidofovir; Cytosine; Facial Dermatoses; Hair Diseases; Hair Follicle; Humans; Inclusion Bodies, Viral; Intranuclear Inclusion Bodies; Lymphoma, Non-Hodgkin; Male; Organophosphonates; Polyomavirus; Treatment Outcome | 2007 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation | 2001 |